189 related articles for article (PubMed ID: 21487039)
1. Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis.
Pei XH; Bai F; Li Z; Smith MD; Whitewolf G; Jin R; Xiong Y
Cancer Res; 2011 Apr; 71(8):2969-77. PubMed ID: 21487039
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53.
Li Z; Xiong Y
Oncogene; 2017 Sep; 36(36):5212-5218. PubMed ID: 28481879
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
4. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
5. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.
Hao Z; Duncan GS; Su YW; Li WY; Silvester J; Hong C; You H; Brenner D; Gorrini C; Haight J; Wakeham A; You-Ten A; McCracken S; Elia A; Li Q; Detmar J; Jurisicova A; Hobeika E; Reth M; Sheng Y; Lang PA; Ohashi PS; Zhong Q; Wang X; Mak TW
J Exp Med; 2012 Jan; 209(1):173-86. PubMed ID: 22213803
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
[TBL] [Abstract][Full Text] [Related]
8. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
[TBL] [Abstract][Full Text] [Related]
9. Parc: a cytoplasmic anchor for p53.
Nikolaev AY; Li M; Puskas N; Qin J; Gu W
Cell; 2003 Jan; 112(1):29-40. PubMed ID: 12526791
[TBL] [Abstract][Full Text] [Related]
10. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
[TBL] [Abstract][Full Text] [Related]
11. Validation of MdmX as a therapeutic target for reactivating p53 in tumors.
Garcia D; Warr MR; Martins CP; Brown Swigart L; Passegué E; Evan GI
Genes Dev; 2011 Aug; 25(16):1746-57. PubMed ID: 21852537
[TBL] [Abstract][Full Text] [Related]
12. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
14. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.
Shi D; Pop MS; Kulikov R; Love IM; Kung AL; Grossman SR
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16275-80. PubMed ID: 19805293
[TBL] [Abstract][Full Text] [Related]
15. RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development.
Su WJ; Fang JS; Cheng F; Liu C; Zhou F; Zhang J
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1720-5. PubMed ID: 23319651
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
[TBL] [Abstract][Full Text] [Related]
17. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
Tembe V; Martino-Echarri E; Marzec KA; Mok MT; Brodie KM; Mills K; Lei Y; DeFazio A; Rizos H; Kettle E; Boadle R; Henderson BR
Cell Signal; 2015 Sep; 27(9):1763-71. PubMed ID: 26022179
[TBL] [Abstract][Full Text] [Related]
18. CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity.
Li Z; Pei XH; Yan J; Yan F; Cappell KM; Whitehurst AW; Xiong Y
Mol Cell; 2014 Jun; 54(5):805-19. PubMed ID: 24793696
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization.
Cubillos-Rojas M; Amair-Pinedo F; Peiró-Jordán R; Bartrons R; Ventura F; Rosa JL
J Biol Chem; 2014 May; 289(21):14782-95. PubMed ID: 24722987
[TBL] [Abstract][Full Text] [Related]
20. The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis.
Huang J; Xu LG; Liu T; Zhai Z; Shu HB
FEBS Lett; 2006 Feb; 580(3):940-7. PubMed ID: 16427630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
